Another interesting target candidate is the transcription factor ETS1, which also had a significant strong SLE genetic association45 and which is in direct PP interaction with SLE drug targets such as JAK3. This protein has been observed to suppress T follicular helper type 2 cell differentiation and halt SLE onset46,47. Here, JAK3 is linked to systemic lupus erythematosus.